NEOLA — Neola Medical AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK86.91m
- SEK60.40m
Annual balance sheet for Neola Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 16.6 | 22.9 | 40.1 | 21.6 | 19.6 |
| Net Total Receivables | 0.563 | 1.45 | 1.02 | 20.9 | 0.98 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 17.4 | 24.8 | 41.6 | 43.1 | 21 |
| Net Property, Plant And Equipment | 0.007 | 0.162 | 0.223 | 0.137 | 0.203 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 26 | 43.8 | 75.3 | 86 | 73.6 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.42 | 3.19 | 5.34 | 6.16 | 4.65 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.42 | 3.19 | 7.84 | 6.99 | 4.65 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 23.5 | 40.6 | 67.5 | 79 | 69 |
| Total Liabilities & Shareholders' Equity | 26 | 43.8 | 75.3 | 86 | 73.6 |
| Total Common Shares Outstanding |